24/7 Customer Support
Valsad, Gujarat, India
WHO-GMP certified fluconazole 150mg tablets for single-dose therapy and vaginal candidiasis treatment with comprehensive global export capabilities.
| Strength | 150mg |
| Dosage Form | Tablets |
| Route | Oral |
| Indications | Vaginal candidiasis, acute infections, single-dose therapy |
| HS Code | 3004.20.90 |
| Regulatory Support | WHO-GMP, ISO 9001, CTD/eCTD dossier |
| Shelf Life | 24-36 months |
| Storage | Room temperature |
| Packaging Options | 1×1 blister packs, 10s, hospital packs |
| Target Markets | Gynecology clinics, hospitals, primary healthcare |
Single-dose therapy for uncomplicated vaginal yeast infections, offering convenience and high patient compliance.
Optimized dosing regimen for improved patient adherence and treatment success in acute fungal infections.
Rapid and effective treatment of acute fungal infections requiring immediate therapeutic intervention.
Valid WHO-GMP certification for international market access
Detailed COA with complete quality parameters
ICH-compliant stability studies for all climate zones
Complete registration dossier for global submissions
Contact our export team for competitive pricing, regulatory support, and seamless global supply chain solutions.